Navigation Links
EpiCept Announces Presentation of New Ceplene(TM) Data at the 49th Annual Meeting of the American Society of Hematology
Date:12/3/2007

TARRYTOWN, N.Y., Dec. 4 /PRNewswire-FirstCall/ -- EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced that it will be presenting new clinical data for Ceplene (histamine dihydrochloride) at the upcoming 49th Annual Meeting of the American Society of Hematology (ASH), taking place in Atlanta, Georgia from December 8-11, 2007. Ceplene is EpiCept's lead oncology product candidate under late stage review by the European Medicines Evaluation Agency (EMEA) for the remission maintenance treatment and prevention of relapse of patients with Acute Myeloid Leukemia (AML) in first remission.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020513/NYM112LOGO )

The results to be presented at the meeting include an analysis of the long-term outcomes of AML patients enrolled in the pivotal Phase III Ceplene study. The new data compares the effects of post-consolidation immunotherapy with histamine dihydrochloride (HDC) in conjunction with low dose interleukin- 2 (IL-2) on leukemia-free survival and overall survival compared to the current standard of care, which is no treatment, at five years post initiation of therapy.

The following poster presentations will be given by EpiCept on Sunday, December 9, 2007 from 9:00 a.m. to 8:00 p.m. Eastern Time at Hall B3 and B4 in the Georgia World Congress Center.

Poster # 36

Title: "Post-consolidation Immunotherapy with Histamine Dihydrochloride

and Interleukin-2 in AML: Long Term Follow-Up of Leukemia-Free Survival

and Overall Survival."

Session Name: Acute Myeloid Leukemias - Therapy, excluding

Transplantation.

Presenter: Mats L. Brune, et al; University of Goteborg, Goteborg,

Sweden.

Poster # 499

Title: "Histamine Dihydrochloride Maintains Cytoxic Effector Lymphocyte

Function and Viability under Conditions of Oxidative Stress."


'/>"/>

SOURCE EpiCept Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. EpiCept Corporation to Present at the 2007 BIO InvestorForum
2. EpiCept to Present Preclinical Studies of EPC2407 in Combination With Anti-Angiogenic and Chemotherpeutic Agents at the AACR-NCI-EORTC International Conference
3. EpiCept Corporation To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. EpiCept To Host Third Quarter 2007 Conference Call and Webcast on November 7, 2007
5. EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results
6. EpiCept Corporation to Present at the BMO Capital Markets 2007 Focus on Healthcare Conference
7. Patient Enrollment Completed in Phase IIb Trial of EpiCept(TM) NP-1 in Diabetic Peripheral Neuropathy
8. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
9. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
10. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
11. HEI, Inc. Announces Sale of RFID Division Assets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Los Angeles, CA (PRWEB) July 24, 2014 ... (FDA), American Optometric Association (AOA) and the Entertainment ... artists from the TV series American Horror Story ... to bring the dramatic realities of illegal ... public service campaign, which has already reached tens-of-thousands, ...
(Date:7/24/2014)... 2014 (HealthDay News) -- A new formulation of a ... or injecting the drug has been approved by the ... and made by Purdue Pharma, the pill is a ... that blocks the euphoric effects of oxycodone. The naloxone ... dissolved or injected, according to the FDA. While ...
(Date:7/24/2014)... 2014, Cleveland: Could the body,s own immune system play ... with conditions like chronic epilepsy, Alzheimer,s dementia and concussions? ... published online by PLOS ONE . , The ... as S100B, which serves as a biomarker for brain ... and spinal column. However, following a brain injury, it ...
(Date:7/24/2014)... PA (PRWEB) July 24, 2014 National ... has announced that it will operate globally under the ... firm remains a woman-owned Employee Stock Ownership Plan (ESOP) ... Susan Schwartz McDonald, Ph.D . The firm guides ... and powerful analytics. , Said McDonald, “We wanted ...
(Date:7/24/2014)... The report, “Feed Palatability Enhancers & Modifiers ... Poultry, Cattle, Pets, Aquaculture, and Others) - Global Trends ... palatability enhancers & modifiers market with an analysis and ... of types of feed flavors, sweeteners, and text rants. ... spread through 275 pages and in-depth TOC on "Feed ...
Breaking Medicine News(10 mins):Health News:Optometric Professionals Team with Hollywood for Second Installment of Video Campaign 2Health News:Optometric Professionals Team with Hollywood for Second Installment of Video Campaign 3Health News:Optometric Professionals Team with Hollywood for Second Installment of Video Campaign 4Health News:FDA Approves Hard-to-Abuse Narcotic Painkiller 2Health News:Immune response may cause harm in brain injuries, disorders 2Health News:National Analysts Worldwide Announces a Change of Name to NAXION 2Health News:National Analysts Worldwide Announces a Change of Name to NAXION 3Health News:Feed Palatability Enhancers & Modifiers Market Worth $3172.6 Million by 2019 - Report by MarketsandMarkets 2Health News:Feed Palatability Enhancers & Modifiers Market Worth $3172.6 Million by 2019 - Report by MarketsandMarkets 3Health News:Feed Palatability Enhancers & Modifiers Market Worth $3172.6 Million by 2019 - Report by MarketsandMarkets 4
... Batesville,Holdings, Inc., a wholly owned subsidiary ... in conjunction with Hillenbrand,s plans to separate ... announced the,appointment of Cynthia L. Lucchese as ... Batesville Holdings, Inc., Batesville Holdings, Inc., ...
... WALTHAM, Mass., Jan. 21 Thermo Fisher,Scientific Inc. (NYSE: ... financial,results for the fourth quarter of 2007 before the ... a conference call on the same,day at 9:00 a.m. ... discuss its fourth quarter financial,performance as well as future ...
... exercise choices may lower risk by almost 80 percent for those ... ... In the wake of New Year,resolutions and American waistlines bulging ever ... in,preventing couples from conceiving., Reproductive specialists say that January is ...
... New Companion Animal ... Veterinarians, OMAHA, Neb., Jan. 21 Meridian ... companion animal veterinary medicine,channel in 2008 with a ... The products, available exclusively through veterinarians,include pharmaceuticals, therapeutics, ...
... But fast food is no friend of the waistline, new study ... whether you eat out, it,s where you choose ... who live in neighborhoods with more fast-food restaurants are more likely ... restaurants, the study found. , "A lot of people have ...
... Key ... the Association, PLEASANT HILL, Calif., Jan. 21 The Mt. ... and founder, Trainer Communications, to its Corporate Executive,Board of Directors. She ... in the middle of a major capital fundraising campaign to rebuild ...
Cached Medicine News:Health News:Batesville Holdings, Inc., Appoints Cynthia L. Lucchese Senior Vice President and Chief Financial Officer 2Health News:Batesville Holdings, Inc., Appoints Cynthia L. Lucchese Senior Vice President and Chief Financial Officer 3Health News:Batesville Holdings, Inc., Appoints Cynthia L. Lucchese Senior Vice President and Chief Financial Officer 4Health News:Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, February 06, 2008 2Health News:Fertility Experts: Winter Waistlines a Swelling Problem for Indianians Trying to Get Pregnant 2Health News:Fertility Experts: Winter Waistlines a Swelling Problem for Indianians Trying to Get Pregnant 3Health News:New Company Enters Companion Animal Veterinary Medicine Channel 2Health News:Eating Out Doesn't Guarantee Weight Gain 2Health News:Eating Out Doesn't Guarantee Weight Gain 3Health News:Mount Diablo Region YMCA Names Local Business Leader, Susan Trainer, to Its Corporate Executive Board 2Health News:Mount Diablo Region YMCA Names Local Business Leader, Susan Trainer, to Its Corporate Executive Board 3Health News:Mount Diablo Region YMCA Names Local Business Leader, Susan Trainer, to Its Corporate Executive Board 4
(Date:7/24/2014)...  Perrigo Company (NYSE: PRGO ; TASE) ... equivalent rating from the U.S. Food and Drug Administration ... for testosterone gel 1.0%. FDA concluded that Perrigo,s testosterone ... can be substituted with the full expectation that it ... as AndroGel 1% when used under the conditions specified ...
(Date:7/24/2014)...  Lazarus Effect, a medical device company focused ... facilitate removal of blood clots, announced today that ... issued a new patent (U.S. Patent Number 8,795,305) ... TM and ReCover TM devices. ... stent-retriever (stentriever) with an integrated, novel, cover-based protection ...
(Date:7/24/2014)... , July 24, 2014  In any given hospital ... 25 patients has at least one hospital-acquired infection, according ... more, many of these infections prove fatal. And as ... alarming number of patient deaths per year, infection control ... Consequently, a stronger emphasis is being ...
Breaking Medicine Technology:Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% 2Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% 3Lazarus Effect Receives Notice of Allowance for New US Patent Covering Core Protection Technology 2Employees, Equipment and the Environment: Top Infection Prevention Focuses in Hospitals 2Employees, Equipment and the Environment: Top Infection Prevention Focuses in Hospitals 3
Lyphochek Hemoglobin A2 Control is a human whole blood based product designed to monitor the performance of automated and manual procedures for the measurement of hemoglobin variants, including Hemog...
... Liquichek Hematology-16 Control ... use on most hematology ... to 16 parameters and ... differentials. This trilevel control ...
Liquichek Hematology Control (C) is an assayed hematology control for evaluating the performance of Coulter hematology instruments with complete CBC and VCS 5-part differential technology....
... Amplichek CT/GC Controls are liquid ... precision of test procedures that ... gonorrhoeae. Since they are specimen ... with either urine or endocervical/urethral ...
Medicine Products: